Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cryoport Inc CYRX

Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its... see more

Recent & Breaking News (NDAQ:CYRX)

Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024

PR Newswire 2 days ago

Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services

PR Newswire 9 days ago

TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics

PR Newswire 10 days ago

VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies

PR Newswire October 15, 2024

Cryoport Launches its IntegriCell(TM) Cryopreservation Solution with Opening of New Facility at its Houston Campus

PR Newswire October 7, 2024

SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices

PR Newswire September 25, 2024

The Schall Law Firm Is Inquiring Into Possible Securities Fraud By Cryoport Inc And Shareholders Are Encouraged To Reach Out

Accesswire August 22, 2024

The Schall Law Firm Is Investigating Cryoport Inc For Potential Securities Law Violations And Invites Investors To Join

Accesswire August 21, 2024

The Schall Law Firm Is Looking Into Cryoport Inc For Possible Securities Law Violations And Encourages Shareholders To Help

Accesswire August 20, 2024

The Schall Law Firm Is Investigating Cryoport Inc For Potential Securities Law Violations And Invites Investors To Help

Accesswire August 19, 2024

The Schall Law Firm Is Inquiring Into Potential Securities Law Violations By Cryoport Inc And Asks Investors To Help

Accesswire August 18, 2024

The Schall Law Firm Is Investigating Cryoport Inc And Asks Investors To Reach Out

Accesswire August 17, 2024

The Schall Law Firm Begins Investigation Into Cryoport Inc And Asks Shareholders To Reach Out

Accesswire August 16, 2024

The Schall Law Firm Opens Investigation Into Cryoport Inc And Encourages Shareholders To Reach Out

Accesswire August 15, 2024

The Schall Law Firm Initiates Investigation Into Claims Against Cryoport Inc And Urges Shareholders To Reach Out

Accesswire August 14, 2024

The Schall Law Firm Initiates Probe Into Allegations Against Cryoport Inc And Motivates Its Shareholders To Contact

Accesswire August 13, 2024

The Schall Law Firm Begins Investigation Into Claims Against Cryoport Inc And Encourages Its Shareholders To Reach Out

Accesswire August 12, 2024

The Schall Law Firm Initiates Investigation Into Claims Against Cryoport Inc And Urges Its Shareholders To Contact

Accesswire August 9, 2024

The Schall Law Firm Begins Probe Into Allegations Against Cryoport Inc And Encourages Its Shareholders To Reach Out

Accesswire August 8, 2024

The Schall Law Firm Initiates Investigation Into Claims Against Cryoport Inc And Urges Its Shareholders To Get In Touch

Accesswire August 7, 2024